Levels of evidence for the pharmacologic effectiveness of prolonged methylprednisolone treatment in unresolving ARDS

Chest

Volumn 116, Issue SUPPL., 1999, Pages

  Meduri, G Umberto ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLUCOCORTICOID; METHYLPREDNISOLONE;

ADULT RESPIRATORY DISTRESS SYNDROME; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG LAVAGE; META ANALYSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0344436033     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.116.suppl_1.116S     Document Type: Conference Paper

References (11)

1. Meduri GU. The role of the host defense response in the progression and outcome of ARDS: pathophysiological correlations and response to glucocorticoid treatment. Eur Respir J 1996; 9:2650-2670
2. Cotran RS, Kumar V, Robbins SL. Cellular injury and cellular death. In: Robbins SL, ed. Pathologic basis of disease. 5th ed. Philadelphia, PA: WB Saunders, 1994; 1-34
3. Meduri GU, Headley S, Kohler G, et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS: plasma IL-1b and IL-6 are consistent and efficient predictors of outcome over time. Chest 1995; 107:1062-1073
4. Meduri GU, Kohler G, Headley S, et al. Inflammatory cytokines in the BAL of patients with ARDS: persistent elevation over time predicts poor outcome. Chest 1995; 108:1303-131
5. Meduri GU, Tolley E, Chinn A, et al. Procollagen type I and III aminoterminal propeptide levels during ARDS and in response to methylprednisolone treatment. Am J Respir Crit Care Med 1998; 158:1432-1441
6. Meduri GU, Chinn AJ, Leeper KV, et al. Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS: patterns of response and predictors of outcome. Chest 1994; 105:1516-1527
7. Meduri GU, Chrousos GP. Duration of glucocorticoid treatment and outcome in sepsis: is the right drug used the wrong way? Chest 1998; 114:355-360
8. Meduri GU, Headley S, Carson S, et al. Prolonged methylprednisolone treatment improves lung function and outcome of unresolving ARDS: a randomized, double-blind, placebo-controlled trial. JAMA 1998; 280:159-165
9. Ashbaugh DG, Maier RV. Idiopathic pulmonary fibrosis in adult respiratory distress syndrome: diagnosis and treatment. Arch Surg 1985; 120:530-535
10. Hooper RG, Kearl RA. Established adult respiratory distress syndrome successfully treated with corticosteroids. South Med J 1996; 89:359-364
11. Meduri GU, Headley S, Tolley E, et al. Plasma and BAL cytokine response to corticosteroid rescue treatment in late ARDS. Chest 1995; 108:1315-1325